Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (3716)	11/16/2000 8:09:23 PM
From: RJMC	Respond to of 5665

I agree that a balanced set of views based on factual data is definitely best for the board. Bob M.

To: tom pope who wrote (3716)	11/16/2000 8:18:29 PM
From: Chi Wong	Read Replies (1) \| Respond to of 5665

I went to the meeting with the "we have the cure" frame of mind and came away with a clearer more conservative outlook. The shareholder meeting was a reality check for me, I don't know about the others. My frame of mind now is more like: "We've probably got the cure but we're not likely going to hear about it for a while thanks to IMGN's stance of 'PR when a milestone is reached' instead of 'science by PR'. I no longer expect an overnight explosion in price due to some ultra-terrific human data for another year or more. Having said this I think Sonny's posts offer a terrific glimpse of what the TA investor is thinking and could foreshadow price trends as long as there's no news to throw off the TA tools.